Weixiao Han

Sinovac Biotech — China

Medicine · Health Sciences

7h-index1.7kcitations11works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral gastroenteritis research and epidemiology(8), Viral Infections and Immunology Research(8), Respiratory viral infections research(5), SARS-CoV-2 and COVID-19 Research(4), COVID-19 Clinical Research Studies(2)

Publications11 total

Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles–Mumps–Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial
Vaccines·2025Open Access
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-labelled, Randomized, Controlled, Phase 4 Clinical Trial
Preprints.org·2025Open Access
Immunogenicity and safety of Sequential Sabin Strain Inactivated Poliovirus Vaccine from Different Manufacturers in Infants: Randomized, Blinded, Controlled trial
SSRN Electronic Journal·2025Open Access
Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months
International Journal of Infectious Diseases·2023· 7 citedOpen Access
Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
Vaccines·2022· 6 citedOpen Access
Cross-neutralization Capacity of Immune Serum from Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization against Multiple Individual Polioviruses
Expert Review of Vaccines·2021· 7 cited
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
The Lancet Infectious Diseases·2020· 1.5k citedOpen Access
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial
2020· 95 citedOpen Access
Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
Open Forum Infectious Diseases·2019· 17 citedOpen Access
A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly
Human Vaccines & Immunotherapeutics·2018· 15 citedOpen Access
Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
Human Vaccines & Immunotherapeutics·2018· 40 citedOpen Access

Frequent Co-authors

Kai Chu(7), Changgui Li(5), Hongxing Pan(4), Fengcai Zhu(4), Deyu Jiang(4), Yuansheng Hu(3), Yuemei Hu(3), Zhiwei Jiang(3), Yanjun Zhang(2), Gang Zeng(2), Yaling Hu(2), Rong Tang(2), Weidong Yin(2), Xiaoyong Liu(2), Congbing Jiang(2), Jingxin Li(2), Minnan Yang(2), Yan Song(2), Xiangxi Wang(2), Guoliang Cui(2)